We read with great interest the article by Cavazza et al., 1 who demonstrated that an advanced histological stage was the only risk factor associated with the development of hepatocellular carcinoma (HCC) in patients with primary biliary cirrhosis (PBC) from two European centers. Similar results wer
High prevalence of multinodular hepatocellular carcinoma in patients with cirrhosis attributable to multiple risk factors
β Scribed by Pierangelo Fasani; Angelo Sangiovanni; Cristina De Fazio; Mauro Borzio; Savino Bruno; G. Ronchi; Ersilio Del Ninno; Massimo Colombo
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 44 KB
- Volume
- 29
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
In Japan, hepatocellular carcinoma (HCC) is one of the most prevalent cancers, with a reported fatality rate showing a consistent and significant increase in the last decade. At most, only 25% of HCC cases are positive for the hepatitis B surface antigen (HBsAg). To investigate a potential role for
## Abstract ## BACKGROUND Inhibitor of differentiation/DNA binding protein 1 (Idβ1) plays a pivotal role in the regulation of cell proliferation and carcinogenesis via inhibiting basic helixβloopβhelix (HLH) transcription factors. Recently, Idβ1 was found to repress p16 in tumorous tissue specimen
## Background: Although experimental studies have demonstrated an important role of insulin-like growth factor i (igf-i) in hepatocarcinogenesis, the clinical data about igf-i in patients with hepatocellular carcinoma (hcc) are scarce and controversial. to the authors' knowledge, this is the first